Advanced search
Publication Cover
Artificial Cells, Nanomedicine, and Biotechnology
An International Journal
Volume 50, 2022 - Issue 1
Submit an article Journal homepage
2,223
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Treatment-related adverse events of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitors in clinical trials: a meta-analysis

Ze Mia Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, ChinaORCID Iconhttps://orcid.org/0000-0001-9075-1606View further author information
ORCID Icon,
Yunshu Zhangb Xiangya School of Medicine, Central South University, Changsha, ChinaView further author information
,
Zhichao Fenga Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, ChinaView further author information
,
Jiahao Liua Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, ChinaView further author information
,
Jianmin Wua Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, ChinaView further author information
,
Hongpei Tana Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, ChinaView further author information
,
Xiaoqian Maa Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, ChinaView further author information
,
Zhenguo Liuc Department of Infectious Disease, The Third Xiangya Hospital, Central South University, Changsha, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-2696-6535View further author information
ORCID Icon &
Pengfei Ronga Department of Radiology, The Third Xiangya Hospital, Central South University, Changsha, China;d Key Laboratory of Biological Nanotechnology of National Health Commission, Central South University, Changsha, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5473-1982View further author information
ORCID Icon show all
Pages 301-309 | Received 25 May 2022, Accepted 14 Sep 2022, Published online: 10 Oct 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.